Cargando…
Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle‐controlled, phase 3 study
Topical metronidazole is not currently approved in Japan as a treatment for the indication of rosacea, although 0.75% metronidazole gel was authorized in 2014 for the management of cancerous skin ulcers. We conducted a randomized, double‐blind, vehicle‐controlled study to evaluate the efficacy and s...
Autores principales: | Miyachi, Yoshiki, Yamasaki, Kenshi, Fujita, Tomomitsu, Fujii, Chie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299697/ https://www.ncbi.nlm.nih.gov/pubmed/34854112 http://dx.doi.org/10.1111/1346-8138.16254 |
Ejemplares similares
-
Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): a brief review.
por: Wain, A M
Publicado: (1998) -
Acridine 0.75-hydrate
por: Schur, Einat, et al.
Publicado: (2011) -
The efficacy of 0.75% levobupivacaine versus 0.75% ropivacaine for peribulbar anesthesia in vitreoretinal surgery
por: Ghali, Ashraf M.
Publicado: (2012) -
Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan
por: Yamasaki, Kenshi, et al.
Publicado: (2022) -
Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study
por: Schaller, Martin, et al.
Publicado: (2016)